APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ulcerative Colitis Medicine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ulcerative Colitis Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17426173034 January 2026192 pages

Choose your research edition.

Industry ResearchUlcerative Colitis Medicine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Ulcerative Colitis Medicine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Ulcerative Colitis Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ulcerative Colitis Medicine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Ulcerative Colitis Medicine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ulcerative Colitis Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Ulcerative Colitis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ulcerative Colitis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ulcerative Colitis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ulcerative Colitis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ulcerative Colitis Medicine include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Ulcerative Colitis Medicine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ulcerative Colitis Medicine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ulcerative Colitis Medicine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Ulcerative Colitis Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Ulcerative Colitis Medicine Segment by Company

Sumitomo

Pfizer

Novartis

Merck

Sanofi

Johnson and Johnson

GSK

AstraZeneca

Cipla

Sun Pharm

Allergan

Teva Pharmaceutical

Ulcerative Colitis Medicine Segment by Type

5-Aminosalicylic Acid

Corticosteroids

Immunomodulator Drugs

Biologics

Ulcerative Colitis Medicine Segment by Application

Ulcerative Proctitis

Proctosigmoiditis

Left-Sided Colitis

Pancolitis

Acute Severe Ulcerative Colitis

Ulcerative Colitis Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ulcerative Colitis Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ulcerative Colitis Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ulcerative Colitis Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Ulcerative Colitis Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ulcerative Colitis Medicine industry.

Chapter 3: Detailed analysis of Ulcerative Colitis Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ulcerative Colitis Medicinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ulcerative Colitis Medicine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 5-Aminosalicylic Acid Table 3. Key Players of Corticosteroids Table 4. Key Players of Immunomodulator Drugs Table 3. Key Players of Biologics Table 4. Global Ulcerative Colitis Medicine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Ulcerative Proctitis Table 6. Key Players of Proctosigmoiditis Table 7. Key Players of Left-Sided Colitis Table 8. Key Players of Pancolitis Table 9. Key Players of Acute Severe Ulcerative Colitis Table 10. Global Ulcerative Colitis Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Ulcerative Colitis Medicine Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Ulcerative Colitis Medicine Market Share by Region (2021-2026) Table 13. Global Ulcerative Colitis Medicine Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Ulcerative Colitis Medicine Market Share by Region (2027-2032) Table 15. Ulcerative Colitis Medicine Industry Trends Table 16. Ulcerative Colitis Medicine Industry Drivers Table 17. Ulcerative Colitis Medicine Industry Opportunities and Challenges Table 18. Ulcerative Colitis Medicine Industry Restraints Table 19. Global Ulcerative Colitis Medicine Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Ulcerative Colitis Medicine Revenue Market Share by Company (2021-2026) Table 21. Global Ulcerative Colitis Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Ulcerative Colitis Medicine Key Company Head Office and Area Served Table 23. Global Ulcerative Colitis Medicine Company, Product Type & Application Table 24. Global Ulcerative Colitis Medicine Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Ulcerative Colitis Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Ulcerative Colitis Medicine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Ulcerative Colitis Medicine Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Ulcerative Colitis Medicine Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Ulcerative Colitis Medicine Revenue Market Share by Type (2021-2026) Table 31. Global Ulcerative Colitis Medicine Revenue Market Share by Type (2027-2032) Table 32. Global Ulcerative Colitis Medicine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ulcerative Colitis Medicine Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Ulcerative Colitis Medicine Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Ulcerative Colitis Medicine Revenue Market Share by Application (2021-2026) Table 36. Global Ulcerative Colitis Medicine Revenue Market Share by Application (2027-2032) Table 37. Sumitomo Company Information Table 38. Sumitomo Business Overview Table 39. Sumitomo Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Sumitomo Ulcerative Colitis Medicine Product Portfolio Table 41. Sumitomo Recent Development Table 42. Pfizer Company Information Table 43. Pfizer Business Overview Table 44. Pfizer Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Pfizer Ulcerative Colitis Medicine Product Portfolio Table 46. Pfizer Recent Development Table 47. Novartis Company Information Table 48. Novartis Business Overview Table 49. Novartis Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Novartis Ulcerative Colitis Medicine Product Portfolio Table 51. Novartis Recent Development Table 52. Merck Company Information Table 53. Merck Business Overview Table 54. Merck Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Merck Ulcerative Colitis Medicine Product Portfolio Table 56. Merck Recent Development Table 57. Sanofi Company Information Table 58. Sanofi Business Overview Table 59. Sanofi Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Sanofi Ulcerative Colitis Medicine Product Portfolio Table 61. Sanofi Recent Development Table 62. Johnson and Johnson Company Information Table 63. Johnson and Johnson Business Overview Table 64. Johnson and Johnson Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Johnson and Johnson Ulcerative Colitis Medicine Product Portfolio Table 66. Johnson and Johnson Recent Development Table 67. GSK Company Information Table 68. GSK Business Overview Table 69. GSK Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. GSK Ulcerative Colitis Medicine Product Portfolio Table 71. GSK Recent Development Table 72. AstraZeneca Company Information Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. AstraZeneca Ulcerative Colitis Medicine Product Portfolio Table 76. AstraZeneca Recent Development Table 77. Cipla Company Information Table 78. Cipla Business Overview Table 79. Cipla Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Cipla Ulcerative Colitis Medicine Product Portfolio Table 81. Cipla Recent Development Table 82. Sun Pharm Company Information Table 83. Sun Pharm Business Overview Table 84. Sun Pharm Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Sun Pharm Ulcerative Colitis Medicine Product Portfolio Table 86. Sun Pharm Recent Development Table 87. Allergan Company Information Table 88. Allergan Business Overview Table 89. Allergan Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Allergan Ulcerative Colitis Medicine Product Portfolio Table 91. Allergan Recent Development Table 92. Teva Pharmaceutical Company Information Table 93. Teva Pharmaceutical Business Overview Table 94. Teva Pharmaceutical Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Teva Pharmaceutical Ulcerative Colitis Medicine Product Portfolio Table 96. Teva Pharmaceutical Recent Development Table 97. North America Ulcerative Colitis Medicine Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Ulcerative Colitis Medicine Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Ulcerative Colitis Medicine Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Ulcerative Colitis Medicine Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Ulcerative Colitis Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Ulcerative Colitis Medicine Market Size by Country (2021-2026) Table 103. North America Ulcerative Colitis Medicine Market Size by Country (2027-2032) Table 104. Europe Ulcerative Colitis Medicine Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Ulcerative Colitis Medicine Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Ulcerative Colitis Medicine Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Ulcerative Colitis Medicine Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Ulcerative Colitis Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Ulcerative Colitis Medicine Market Size by Country (2021-2026) Table 110. Europe Ulcerative Colitis Medicine Market Size by Country (2027-2032) Table 111. China Ulcerative Colitis Medicine Market Size by Type (2021-2026) & (US$ Million) Table 112. China Ulcerative Colitis Medicine Market Size by Type (2027-2032) & (US$ Million) Table 113. China Ulcerative Colitis Medicine Market Size by Application (2021-2026) & (US$ Million) Table 114. China Ulcerative Colitis Medicine Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Ulcerative Colitis Medicine Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Ulcerative Colitis Medicine Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Ulcerative Colitis Medicine Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Ulcerative Colitis Medicine Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Ulcerative Colitis Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Ulcerative Colitis Medicine Market Size by Country (2021-2026) Table 121. Asia Ulcerative Colitis Medicine Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Ulcerative Colitis Medicine Product Image Figure 2. Global Ulcerative Colitis Medicine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Ulcerative Colitis Medicine Market Share by Type: 2025 VS 2032 Figure 4. 5-Aminosalicylic Acid Image Figure 5. Corticosteroids Image Figure 6. Immunomodulator Drugs Image Figure 7. Biologics Image Figure 8. Global Ulcerative Colitis Medicine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Ulcerative Colitis Medicine Market Share by Application: 2025 VS 2032 Figure 10. Ulcerative Proctitis Image Figure 11. Proctosigmoiditis Image Figure 12. Left-Sided Colitis Image Figure 13. Pancolitis Image Figure 14. Acute Severe Ulcerative Colitis Image Figure 15. Global Ulcerative Colitis Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 17. Global Ulcerative Colitis Medicine Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Ulcerative Colitis Medicine Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Ulcerative Colitis Medicine Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Ulcerative Colitis Medicine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Ulcerative Colitis Medicine Revenue Market Share by Type (2021-2032) Figure 24. Global Ulcerative Colitis Medicine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Ulcerative Colitis Medicine Revenue Market Share by Application (2021-2032) Figure 26. North America Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 27. North America Ulcerative Colitis Medicine Market Share by Type (2021-2032) Figure 28. North America Ulcerative Colitis Medicine Market Share by Application (2021-2032) Figure 29. North America Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 30. United States Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 31. Canada Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 33. Europe Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 34. Europe Ulcerative Colitis Medicine Market Share by Type (2021-2032) Figure 35. Europe Ulcerative Colitis Medicine Market Share by Application (2021-2032) Figure 36. Europe Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 37. Germany Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 38. France Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 40. Italy Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 41. Russia Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 43. China Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 44. China Ulcerative Colitis Medicine Market Share by Type (2021-2032) Figure 45. China Ulcerative Colitis Medicine Market Share by Application (2021-2032) Figure 46. Asia Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 47. Asia Ulcerative Colitis Medicine Market Share by Type (2021-2032) Figure 48. Asia Ulcerative Colitis Medicine Market Share by Application (2021-2032) Figure 49. Asia Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 50. Japan Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 54. India Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 55. Australia Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Ulcerative Colitis Medicine Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Ulcerative Colitis Medicine Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Ulcerative Colitis Medicine Market Share by Country (2021-2032) Figure 60. Brazil Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 65. UAE Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 67. Chile Ulcerative Colitis Medicine Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 5-Aminosalicylic Acid
  • Corticosteroids
  • Immunomodulator Drugs
  • Biologics
Applications
  • Ulcerative Proctitis
  • Proctosigmoiditis
  • Left-Sided Colitis
  • Pancolitis
  • Acute Severe Ulcerative Colitis
Companies covered
  • Sumitomo
  • Pfizer
  • Novartis
  • Merck
  • Sanofi
  • Johnson and Johnson
  • GSK
  • AstraZeneca
  • Cipla
  • Sun Pharm
  • Allergan
  • Teva Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Ulcerative Colitis Medicine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 5-Aminosalicylic Acid
  5. 1.2.3 Corticosteroids
  6. 1.2.4 Immunomodulator Drugs
  7. 1.2.5 Biologics
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Ulcerative Colitis Medicine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Ulcerative Proctitis
  11. 1.3.3 Proctosigmoiditis
  12. 1.3.4 Left-Sided Colitis
  13. 1.3.5 Pancolitis
  14. 1.3.6 Acute Severe Ulcerative Colitis
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Ulcerative Colitis Medicine Growth Trends by Region
  17. 1.5.1 Global Ulcerative Colitis Medicine Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Ulcerative Colitis Medicine Market Size by Region (2021-2026)
  19. 1.5.3 Ulcerative Colitis Medicine Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Ulcerative Colitis Medicine Market Dynamics
  1. 2.1 Ulcerative Colitis Medicine Industry Trends
  2. 2.2 Ulcerative Colitis Medicine Industry Drivers
  3. 2.3 Ulcerative Colitis Medicine Industry Opportunities and Challenges
  4. 2.4 Ulcerative Colitis Medicine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Ulcerative Colitis Medicine Revenue by Company (2021-2026)
  2. 3.2 Global Ulcerative Colitis Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Ulcerative Colitis Medicine Key Company Head office and Area Served
  4. 3.4 Global Ulcerative Colitis Medicine Company, Product Type & Application
  5. 3.5 Global Ulcerative Colitis Medicine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Ulcerative Colitis Medicine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Ulcerative Colitis Medicine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Ulcerative Colitis Medicine Tier 1, Tier 2, and Tier 3
4 Ulcerative Colitis Medicine Market by Type
  1. 4.1 Global Ulcerative Colitis Medicine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Ulcerative Colitis Medicine Market Size by Type (2021-2032)
  3. 4.3 Global Ulcerative Colitis Medicine Market Size Share by Type (2021-2032)
5 Ulcerative Colitis Medicine Market by Application
  1. 5.1 Global Ulcerative Colitis Medicine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Ulcerative Colitis Medicine Market Size by Application (2021-2032)
  3. 5.3 Global Ulcerative Colitis Medicine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sumitomo
  2. 6.1.1 Sumitomo Company Information
  3. 6.1.2 Sumitomo Business Overview
  4. 6.1.3 Sumitomo Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sumitomo Ulcerative Colitis Medicine Product Portfolio
  6. 6.1.5 Sumitomo Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Ulcerative Colitis Medicine Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis Ulcerative Colitis Medicine Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck Ulcerative Colitis Medicine Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sanofi Ulcerative Colitis Medicine Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Johnson and Johnson
  32. 6.6.1 Johnson and Johnson Company Information
  33. 6.6.2 Johnson and Johnson Business Overview
  34. 6.6.3 Johnson and Johnson Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Johnson and Johnson Ulcerative Colitis Medicine Product Portfolio
  36. 6.6.5 Johnson and Johnson Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GSK Ulcerative Colitis Medicine Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 AstraZeneca Ulcerative Colitis Medicine Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Cipla
  50. 6.9.1 Cipla Company Information
  51. 6.9.2 Cipla Business Overview
  52. 6.9.3 Cipla Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Cipla Ulcerative Colitis Medicine Product Portfolio
  54. 6.9.5 Cipla Recent Developments
  55. 6.10 Sun Pharm
  56. 6.10.1 Sun Pharm Company Information
  57. 6.10.2 Sun Pharm Business Overview
  58. 6.10.3 Sun Pharm Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sun Pharm Ulcerative Colitis Medicine Product Portfolio
  60. 6.10.5 Sun Pharm Recent Developments
  61. 6.11 Allergan
  62. 6.11.1 Allergan Company Information
  63. 6.11.2 Allergan Business Overview
  64. 6.11.3 Allergan Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Allergan Ulcerative Colitis Medicine Product Portfolio
  66. 6.11.5 Allergan Recent Developments
  67. 6.12 Teva Pharmaceutical
  68. 6.12.1 Teva Pharmaceutical Company Information
  69. 6.12.2 Teva Pharmaceutical Business Overview
  70. 6.12.3 Teva Pharmaceutical Ulcerative Colitis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Teva Pharmaceutical Ulcerative Colitis Medicine Product Portfolio
  72. 6.12.5 Teva Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Ulcerative Colitis Medicine Market Size (2021-2032)
  2. 7.2 North America Ulcerative Colitis Medicine Market Size by Type
  3. 7.2.1 North America Ulcerative Colitis Medicine Market Size by Type (2021-2026)
  4. 7.2.2 North America Ulcerative Colitis Medicine Market Size by Type (2027-2032)
  5. 7.2.3 North America Ulcerative Colitis Medicine Market Share by Type (2021-2032)
  6. 7.3 North America Ulcerative Colitis Medicine Market Size by Application
  7. 7.3.1 North America Ulcerative Colitis Medicine Market Size by Application (2021-2026)
  8. 7.3.2 North America Ulcerative Colitis Medicine Market Size by Application (2027-2032)
  9. 7.3.3 North America Ulcerative Colitis Medicine Market Share by Application (2021-2032)
  10. 7.4 North America Ulcerative Colitis Medicine Market Size by Country
  11. 7.4.1 North America Ulcerative Colitis Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  13. 7.4.3 North America Ulcerative Colitis Medicine Market Size by Country (2027-2032)
  14. 7.4.4 North America Ulcerative Colitis Medicine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Ulcerative Colitis Medicine Market Size (2021-2032)
  2. 8.2 Europe Ulcerative Colitis Medicine Market Size by Type
  3. 8.2.1 Europe Ulcerative Colitis Medicine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Ulcerative Colitis Medicine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Ulcerative Colitis Medicine Market Share by Type (2021-2032)
  6. 8.3 Europe Ulcerative Colitis Medicine Market Size by Application
  7. 8.3.1 Europe Ulcerative Colitis Medicine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Ulcerative Colitis Medicine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Ulcerative Colitis Medicine Market Share by Application (2021-2032)
  10. 8.4 Europe Ulcerative Colitis Medicine Market Size by Country
  11. 8.4.1 Europe Ulcerative Colitis Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Ulcerative Colitis Medicine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Ulcerative Colitis Medicine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Ulcerative Colitis Medicine Market Size (2021-2032)
  2. 9.2 China Ulcerative Colitis Medicine Market Size by Type
  3. 9.2.1 China Ulcerative Colitis Medicine Market Size by Type (2021-2026)
  4. 9.2.2 China Ulcerative Colitis Medicine Market Size by Type (2027-2032)
  5. 9.2.3 China Ulcerative Colitis Medicine Market Share by Type (2021-2032)
  6. 9.3 China Ulcerative Colitis Medicine Market Size by Application
  7. 9.3.1 China Ulcerative Colitis Medicine Market Size by Application (2021-2026)
  8. 9.3.2 China Ulcerative Colitis Medicine Market Size by Application (2027-2032)
  9. 9.3.3 China Ulcerative Colitis Medicine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Ulcerative Colitis Medicine Market Size (2021-2032)
  2. 10.2 Asia Ulcerative Colitis Medicine Market Size by Type
  3. 10.2.1 Asia Ulcerative Colitis Medicine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Ulcerative Colitis Medicine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Ulcerative Colitis Medicine Market Share by Type (2021-2032)
  6. 10.3 Asia Ulcerative Colitis Medicine Market Size by Application
  7. 10.3.1 Asia Ulcerative Colitis Medicine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Ulcerative Colitis Medicine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Ulcerative Colitis Medicine Market Share by Application (2021-2032)
  10. 10.4 Asia Ulcerative Colitis Medicine Market Size by Country
  11. 10.4.1 Asia Ulcerative Colitis Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Ulcerative Colitis Medicine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Ulcerative Colitis Medicine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Ulcerative Colitis Medicine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Ulcerative Colitis Medicine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Ulcerative Colitis Medicine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Ulcerative Colitis Medicine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst